Joseph Scheeren is Senior Vice President and Global Head of Regulatory Affairs for Pharma & Consumer Health at Bayer. He is responsible for leading the Regulatory Affairs organization to obtain product approvals, anticipate health authority actions, and maintain compliance with global regulations.
Dr. Scheeren has 30 years of global experience, working in France, Germany, Switzerland, US and China. He joined Bayer Pharmaceuticals in 2004, responsible for Development in the US. He was confirmed in his VP role during the merger with Schering and became site head of Montville, NJ in 2009. In October 2012 he was appointed Head of Global Development Asia, located in Beijing, China. Since January 2015, he is Global Head of Regulatory Affairs Pharma and Consumer Health, located in Basel, Switzerland.
Prior to Bayer, he led the Global Marketed Product Regulatory Affairs Department of Aventis and previously HMR between 1996 and 2000. He led Global Regulatory Affairs at Roussel UCLAF in Paris, France from 1992-2000. Between 1991 and 1992, he led World-Wide Regulatory Affairs at Serono in Geneva, Switzerland. He started in the pharmaceutical industry with Servier in Paris in 1982 and was responsible for Regulatory Affairs Northern and Eastern Europe, and from 1986-87 directed Servier’s clinical development antenna in Munich, Germany.
Dr. Scheeren was born and raised in the Netherlands and studied pharmacy at the University of Leiden.
Dr. Scheeren is active in several industry organizations. He is a member of the Drug Information Association (DIA) Board of Directors, the Centre for Innovation in Regulatory Science (CIRS) Regulatory Advisory Board and Administrative Board, the Yale University Regulatory Affairs Track Advisory Board, and the Advisory Board of the Center of Regulatory Excellence (CoRE) in Singapore. Dr. Scheeren is also an elected corresponding Member of the Academie Nationale de Pharmacie in France and a lecturer at Yale University.